Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-006980
Filing Date
2021-02-17
Accepted
2021-02-17 18:55:39
Documents
2
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1558
2 EX-24 DOCUMENT attachment1.htm EX-24 3247
  Complete submission text file 0000899243-21-006980.txt   6216
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCPHARMACEUTICALS INC. 2400 DISTRICT AVENUE, SUITE 310 BURLINGTON MA 01803
Business Address
Abraham William Tober (Reporting) CIK: 0001846086 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 21646862